Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene

Translational Psychiatry

Volumn 3, Issue , 2013, Pages

  Perroud, N ^a,b   Salzmann, A ^a   Prada, P ^b   Nicastro, R ^b   Hoeppli, M E ^b   Furrer, S ^b   Ardu, S ^a   Krejci, I ^a   Karege, F ^b   Malafosse, A ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

BDNF; borderline personality disorder; DBT; epigenetic; psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; BEHAVIOR THERAPY; BORDERLINE STATE; CHILD ABUSE; CONTROLLED STUDY; CPG ISLAND; DEPRESSION; DNA METHYLATION; EPIGENETICS; FEMALE; FOLLOW UP; HOPELESSNESS; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME; TREATMENT RESPONSE; CLASSIFICATION; DOWN REGULATION; DRUG ANTAGONISM; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY;

ADULT; BORDERLINE PERSONALITY DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD ABUSE; CHILD, PRESCHOOL; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 84880869360     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.140     Document Type: Article

References (45)

1. Leichsenring F, Leibing E, Kruse J, New AS, Leweke F. Borderline personality disorder. Lancet 2011; 377: 74-84.
2. Perroud N, Paoloni-Giacobino A, Prada P, Olié E, Salzmann A, Nicastro R et al. Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry 2011; 1: e59.
3. Wagner S, Baskaya O, Dahmen N, Lieb K, Tadic A. Modulatory role of the brain-derived neurotrophic factor Val66Met polymorphism on the effects of serious life events on impulsive aggression in borderline personality disorder. Genes Brain Behav 2010; 9: 97-102.
4. Tadic A, Elsasser A, Victor A, von Cube R, Baskaya O, Wagner S et al. Association analysis of serotonin receptor 1B (HTR1B) and brain-derived neurotrophic factor gene polymorphisms in Borderline personality disorder. J Neural Transm 2009; 116: 1185-1188.
5. Koenigsberg HW, Yuan P, Diaz GA, Guerreri S, Dorantes C, Mayson S et al. Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients. Psychiatry Res 2012; 199: 92-97.
6. Elzinga BM, Molendijk ML, Oude Voshaar RC, Bus BA, Prickaerts J, Spinhoven P et al. The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met. Psychopharmacology (Berl) 2011; 214: 319-328.
7. Kozlovsky N, Matar MA, Kaplan Z, Kotler M, Zohar J, Cohen H. Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response. Int J Neuropsychopharmacol 2007; 10: 741-758.
8. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006; 9: 519-525.
9. Roth TL, Zoladz PR, Sweatt JD, Diamond DM. Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder. J Psychiatr Res 2011; 45: 919-926.
10. Lubin FD, Roth TL, Sweatt JD. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 2008; 28: 10576-10586.
11. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 2009; 65: 760-769.
12. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010; 67: 258-267.
13. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64: 527-532.
14. Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 2011; 16: 1088-1095.
15. Lopez JP, Mamdani F, Labonte B, Beaulieu MM, Yang JP, Berlim MT et al. Epigenetic regulation of BDNF expression according to antidepressant response. Mol Psychiatry advance online publication, 1 May 2012; doi:10.1038/mp.2012.38.
16. Chen ES, Ernst C, Turecki G. The epigenetic effects of antidepressant treatment on human prefrontal cortex BDNF expression. Int J Neuropsychopharmacol 2011; 14: 427-429.
17. Perroud N, Uher R, Dieben K, Nicastro R, Huguelet P. Predictors of response and drop-out during intensive dialectical behavior therapy. J Pers Disord 2010; 24: 634-650.
18. Perroud N, Nicastro R, Jermann F, Huguelet P. Mindfulness skills in borderline personality disorder patients during dialectical behavior therapy: preliminary results. Int J Psychiatry Clin Pract 2012; 16: 189-196.
19. First M, Gibbon M, Spitzer R, Williams JBW, Smith Benjamin L. Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). American Psychiatric Association: Washington DC, 1994.
20. Preisig M, Fenton BT, Matthey ML, Berney A, Ferrero F. Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Eur Arch Psychiatry Clin Neurosci 1999; 249: 174-179.
21. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 1996; 67: 588-597.
22. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974; 42: 861-865.
23. Bayle FJ, Bourdel MC, Caci H, Gorwood P, Chignon JM, Ades J et al. [Factor analysis of French translation of the Barratt impulsivity scale (BIS-10)]. Can J Psychiatry 2000; 45: 156-165.
24. Bernstein DP, Fink L. Childhood Trauma Questionnaire. A Retrospective Self-Report. The Psychological Corporation: San Antonio, USA, 1998.
25. McQuillan A, Nicastro R, Guenot F, Girard M, Lissner C, Ferrero F. Intensive dialectical behavior therapy for outpatients with borderline personality disorder who are in crisis. Psychiatr Serv 2005; 56: 193-197.
26. Wojdacz TK, Dobrovic A, Algar EM. Rapid detection of methylation change at H19 in human imprinting disorders using methylation-sensitive high-resolution melting. Hum Mutat 2008; 29: 1255-1260.
27. Wojdacz TK, Dobrovic A, Hansen LL. Methylation-sensitive high-resolution melting. Nat Protoc 2008; 3: 1903-1908.
28. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57: 1068-1072.
29. Uher R, Maier W, Hauser J, Marusic A, Schmael C, Mors O et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry 2009; 194: 251-258.
30. Rabe-Hesketh S, Skrondal A. Multilevel and Longitudinal Modeling Using Stata. Stata Press: College Station, TX, 2005.
31. D'Addario C, Dell'Osso B, Palazzo MC, Benatti B, Lietti L, Cattaneo E et al. Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology 2012; 37: 1647-1655.
32. Dammann G, Teschler S, Haag T, Altmuller F, Tuczek F, Dammann RH. Increased DNA methylation of neuropsychiatric genes occurs in borderline personality disorder. Epigenetics 2011; 6: 1454-1462.
33. McGowan PO, Suderman M, Sasaki A, Huang TC, Hallett M, Meaney MJ et al. Broad epigenetic signature of maternal care in the brain of adult rats. PLoS One 2011; 6: e14739.
34. McGowan PO, Szyf M. The epigenetics of social adversity in early life: implications for mental health outcomes. Neurobiol Dis 2010; 39: 66-72.
35. Fuchikami M, Yamamoto S, Morinobu S, Takei S, Yamawaki S. Epigenetic regulation of BDNF gene in response to stress. Psychiatry Investig 2010; 7: 251-256.
36. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148.
37. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-75.
38. Boulle F, van den Hove DL, Jakob SB, Rutten BP, Hamon M, van Os J et al. Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry 2012; 17: 584-596.
39. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007; 90: 397-406.
40. An JJ, Gharami K, Liao GY, Woo NH, Lau AG, Vanevski F et al. Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 2008; 134: 175-187.
41. Barker PA. Whither proBDNF? Nat Neurosci 2009; 12: 105-106.
42. Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M et al. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 1993; 10: 475-489.
43. Im HI, Hollander JA, Bali P, Kenny PJ. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 2010; 13: 1120-1127.
44. Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ et al. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am J Med Genet B Neuropsychiatr Genet 2005; 134B: 93-103.
45. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J et al. Brainderived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002; 87: 728-734.